Literature DB >> 3830246

Skeletal muscle binding and renal excretion of digoxin in man.

K Schenck-Gustafsson, T Jogestrand, R Dahlqvist.   

Abstract

Ten healthy subjects were treated with three or four different doses of digoxin, 0.25 to 0.88 mg daily, in random order. Digoxin concentrations in serum (SDC) and skeletal muscle (SMDC) were determined as well as its renal clearance after 2 weeks of treatment with each dose. The mean ratio SMDC/SDC decreased non-significantly by about 20% from 33 +/- 15 at the lowest SDC interval (0.5-0.9 nmol/l) to 28 +/- 7 at the highest concentration interval (2.0-2.4 nmol/l). This is in accordance with findings from previous studies. No significant change was observed in the renal clearance of digoxin with increasing digoxin concentration, supporting the concept of first-order renal elimination of digoxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3830246     DOI: 10.1007/bf00606638

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  [Serum creatinine determination without protein precipitation].

Authors:  H Bartels; M Böhmer; C Heierli
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

2.  Cardiac effects of treatment with quinidine and digoxin, alone and in combination.

Authors:  K Schenck-Gustafsson; T Jogestrand; L A Brodin; R Nordlander; R Dahlqvist
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

3.  Effect of quinidine on digoxin concentration in skeletal muscle and serum in patients with atrial fibrillation. Evidence for reduced binding of digoxin in muscle.

Authors:  K Schenck-Gustafsson; T Jogestrand; R Nordlander; R Dahlqvist
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

4.  Renal digoxin clearance: dependence on plasma digoxin and diuresis.

Authors:  E Steiness; S Waldorff; P B Hansen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  The renal clearance of digoxin is dependent upon the serum digoxin concentration.

Authors:  T P Gibson; A P Quintanilla
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

6.  Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle.

Authors:  T Jogestrand; K Schenck-Gustafsson; R Nordlander; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

Authors:  T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

8.  Effect of acute changes in serum digoxin concentration on renal digoxin clearance.

Authors:  T P Gibson; H S Ribner; A P Quintanilla
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

9.  Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.

Authors:  T Jogestrand; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

  9 in total
  1 in total

1.  Oral digoxin effects on exercise performance, K+ regulation and skeletal muscle Na+ ,K+ -ATPase in healthy humans.

Authors:  Simon Sostaric; Aaron C Petersen; Craig A Goodman; Xiaofei Gong; Tai-Juan Aw; Malcolm J Brown; Andrew Garnham; Collene H Steward; Kate T Murphy; Kate A Carey; James Leppik; Steve F Fraser; David Cameron-Smith; Henry Krum; Rodney J Snow; Michael J McKenna
Journal:  J Physiol       Date:  2022-08-02       Impact factor: 6.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.